カテゴリ： MarketLine, 企業調査, 日本

Nohmi Bosai Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Nohmi Bosai Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C10227
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：21
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：産業装置
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Nohmi Bosai Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Nohmi Bosai Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Nohmi Bosai Ltd. (Nohmi) is a fire protection system manufacturer. It develops markets, installs and maintains a range of fire protection systems. The company’s portfolio of products includes automatic fire alarm systems, fire extinguishing systems, dry chemical extinguishing systems, heat and gas dispersion control systems, fire doors, environmental monitoring systems, and smoke control systems. The company also offers maintenance and inspection services such as telephone support, online monitoring and repair. In addition, it carries out installation and maintenance services of parking lot driving lane control systems. The company’s solutions find application in various home, commercial, and industrial facilities. It serves across South Asia, the Middle East, Africa and the US though distributors and representative offices. Nohmi is headquartered in Tokyo, Japan.

Scope

- Detailed information on Nohmi Bosai Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Nohmi Bosai Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Nohmi Bosai Ltd including a breakdown and examination of key business segments
- Intelligence on Nohmi Bosai Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Nohmi Bosai Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Nohmi Bosai Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Nohmi Bosai Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Nohmi Bosai Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Nohmi Bosai Ltd: Company Overview 6
Nohmi Bosai Ltd: Overview and Key Facts 6
Nohmi Bosai Ltd: Overview 6
Nohmi Bosai Ltd: Key Facts 6
Nohmi Bosai Ltd: Key Employees 8
Nohmi Bosai Ltd: Major Products and Services 9
Nohmi Bosai Ltd: Company History 10
Nohmi Bosai Ltd: Management Statement 11
Nohmi Bosai Ltd: Locations and Subsidiaries 13
Nohmi Bosai Ltd: Key Competitors 14
Nohmi Bosai Ltd: Company Analysis 15
Nohmi Bosai Ltd: Business Description 15
Nohmi Bosai Ltd: SWOT Analysis 16
Nohmi Bosai Ltd: SWOT Overview 16
Nohmi Bosai Ltd: Strengths 16
Nohmi Bosai Ltd: Weaknesses 17
Nohmi Bosai Ltd: Opportunities 17
Nohmi Bosai Ltd: Threats 18
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20

List of Tables
Table 1: Nohmi Bosai Ltd: Key Facts
Table 2: Nohmi Bosai Ltd: Key Employees
Table 3: Nohmi Bosai Ltd: Company History
Table 4: Nohmi Bosai Ltd: Locations and Subsidiaries
Table 5: Nohmi Bosai Ltd: Key Competitors



★海外企業調査レポート[Nohmi Bosai Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • IPCA Laboratories Ltd (IPCALAB)：企業の財務・戦略的SWOT分析
    Summary IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmin …
  • Lumosa Therapeutics Co Ltd (6535)：製薬・医療：M&Aディール及び事業提携情報
    Summary Lumosa Therapeutics Co Ltd (Lumosa Therapeutics) is a developer of drugs for the treatment of neurological and inflammatory diseases. The company’s pipeline products include LT-1001, an analgesic injection for severe pain relief; and LT-3001, a novel small molecule for acute ischemic stroke. …
  • Vexim SA (ALVXM)：企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Oriflame Holding AG：企業の戦略・SWOT・財務分析
    Oriflame Holding AG - Strategy, SWOT and Corporate Finance Report Summary Oriflame Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Paranta Biosciences Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Paranta Biosciences Ltd (Paranta Biosciences) is a clinical stage biopharmaceutical company which develops follistatin-based bio-therapeutic for the treatment of inflammatory and fibrotic diseases. The company’s lead product candidate PB01, a recombinant human follistatin-288 is under phase …
  • Hotel Grand Central Limited：企業の戦略・SWOT・財務情報
    Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Grand Central Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Crownhaitai Holdings Co Ltd：企業の戦略・SWOT・財務情報
    Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hamilton Thorne Ltd (HTL)：企業の財務・戦略的SWOT分析
    Summary Hamilton Thorne Ltd (Hamilton Thorne) is a medical equipment company that offers precision laser devices and advanced image analysis systems. The company's products include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis products, sperm …
  • Vericel Corp (VCEL)：医療機器：M&Aディール及び事業提携情報
    Summary Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn domains. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts fo …
  • Tat Seng Packaging Group Ltd. (T12)：企業の戦略的SWOT分析
    Tat Seng Packaging Group Ltd. (T12) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • AMAG Pharmaceuticals Inc (AMAG)-医療機器分野：企業M&A・提携分析
    Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) …
  • First Solar Inc (FSLR)：企業の財務・戦略的SWOT分析
    First Solar Inc (FSLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Dollarama Inc：戦略・SWOT・企業財務分析
    Dollarama Inc - Strategy, SWOT and Corporate Finance Report Summary Dollarama Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Companhia Energetica de Sao Paulo (CESP6)：企業の財務・戦略的SWOT分析
    Companhia Energetica de Sao Paulo (CESP6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Maruho Co Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Maruho Co Ltd (Maruho) is a pharmaceutical company that carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers produ …
  • Eesti Energia AS：戦略・SWOT・企業財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • APIM Therapeutics AS-製薬・医療分野：企業M&A・提携分析
    Summary APIM Therapeutics AS (APIM) is a drug development company that offers novel anti-cancer therapies. The company offers development of peptide compounds such as mitomycin-c, cisplatin, melphatan, ATX compounds, cytarabine, cisplatin, docetaxel and temozolomide. Its compounds are used in indica …
  • Helix BioPharma Corp (HBP)-製薬・医療分野：企業M&A・提携分析
    Summary Helix BioPharma Corp (Helix) is a biopharmaceutical company with a focus in the field of cancer therapy. The company develops drug candidates for the prevention and treatment of cancer. It develops drugs based on its proprietary technologies. DOS47, the company's proprietary broad anti-cance …
  • Alamo Group Inc (ALG)：企業の財務・戦略的SWOT分析
    Alamo Group Inc (ALG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Securian Financial Group, Inc.：企業の戦略・SWOT・財務情報
    Securian Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Securian Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆